A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 476.68
C 34.23
GOOG 609.85
BAC 8.13
RIMM 16.49

Recently Added

SHMX 0.00
NBTH 12.79
COHO 0.00
PZZI 6.19
AIMH 0.01

Gaining Speed

COHO 0.00
SHMX 0.00
NBTH 12.79
AVEW 0.00
IDVC 0.35
32.76 -0.29 (-0.88%) RDY

Click Here to Receive Instant E-mail and RSS Alerts


Trade RDY now with

Stock Details

Last Trade:32.76 Change:-0.29 (-0.88%) Prev Close:33.05 Open: 33.00 Days Range:32.75 – 33.07 52 Week Range: 28.75 - 39.37 Volume:160025 P/E: N/A
EPS:0.00

Member Comments

No member comments available for RDY


Not logged in - Log in or Sign up to leave comments





View AllRecent Alerts 02/09/12

Recent Alert on 02/07/12 at 10:50am
Credit Suisse Downgrades Dr. Reddy's Laboratories (RDY) to Neutral

Credit Suisse downgraded Dr. Reddy's Laboratories (NYSE: RDY) from Buy to Neutral. For an analyst ratings summary and ratings history on Dr. Reddy's Laboratories click here. For more ratings news on Dr. Reddy's Laboratories click here. Shares... Read More

Recent Alert on 02/03/12 at 6:24am
Dr. Reddys Labs (RDY) Reports Q3 Earnings of $0.60
Recent Alert on 02/02/12 at 5:43pm
Trading Radar for 02/03: Tyson Foods (TSN), Clorox (CLX), Moneygram (MGI), BEAM (BEAM) Report
Recent Alert on 01/27/12 at 6:58am
Dr. Reddy’s Laboratories (RDY) Comments on Recent Media Reports
Recent Alert on 01/27/12 at 6:58am
Dr. Reddy’s Laboratories (RDY) Comments on Recent Media Reports

View AllRecent Press Releases

No Recent Press Releases Available

View AllRecent SEC Filings

SEC Filing on 02/06/12 at 6:16am
Form 6-K DR REDDYS LABORATORIES For: Feb 06

View AllRecent Blog Posts

Blog Posts on 02/03/12 at 5:50pm
Dr. Reddy's Laboratories' CEO Discusses Q3 2012 Results - Earnings Call Transcript
Blog Posts on 02/03/12 at 10:08am
Pharma Grows In Importance To India's Nifty Fifty
Blog Posts on 01/02/12 at 7:01am
New India Consumer ETF Looks Promising
Blog Posts on 12/29/11 at 2:06pm
Dr. Reddy's: Underperformer In The U.S., Outperformer In India
Blog Posts on 11/02/11 at 12:08pm
10 Dividend Stocks That Keep Slipping Lower Despite Impressive Earnings Growth